Related Experiment Video

Updated: May 13, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Perceptions and needs of community pharmacy teams when caring for pediatric oncology patients : A multicenter study

C Moreau1, C Fronteau1, D Navas1

  • 1Pharmacie, Nantes University Hospital, Nantes, France.

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|May 12, 2026
PubMed

Insights

Community pharmacy teams need better resources and training to support children with cancer. Improving coordination between community and hospital care is essential for enhancing pediatric oncology patient pathways.

Area of Science:

  • Pharmacy Practice
  • Pediatric Oncology
  • Healthcare Delivery

Background:

  • Community pharmacy staff are vital in pediatric cancer care.
  • Challenges include cancer diversity, rarity, and complex treatments.
  • Existing literature lacks focus on community pharmacy team needs in this area.

Purpose of the Study:

  • To explore community pharmacy teams' perceptions and needs.
  • To identify improvements for pediatric oncology patient care pathways.
  • To address the gap in scientific literature regarding this specific research question.

Main Methods:

  • Descriptive, non-randomized, multicenter study.
  • Online questionnaire for community pharmacy professionals in western France.
  • Data collected anonymously from 49 participating pharmacy teams.

Main Results:

  • Lack of resources (100%) and insufficient training (98%) were primary difficulties.
  • Limited coordination between community and hospital settings reported by 87.8%.
  • Teams showed high motivation and interest in tailored pediatric oncology training.

Conclusions:

  • Develop practical tools like interactive platforms and patient resources.
  • Enhance communication and diversify training methods (e.g., webinars).
  • Improve collaboration between community and hospital-based care for better pediatric cancer patient journeys.

Keywords:
community pharmaciescoordinated care pathwaypediatrics

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...